Kojic acid in vitro percutaneous penetration study;Permeação cutânea in vitro do ácido kójico

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 43, Issue 2, 2007, Pages 195-203

  Sato, Mayumi Eliza Otsuka ^a   Gomara, Fernanda ^a   Pontarolo, Roberto ^a   Andreazza, Itamar Francisco ^a   Zaroni, Mariella ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Depigmenting agent; In vitro cutaneous permeation; Kojic acid

Indexed keywords

BUFFER; KOJIC ACID;

ANIMAL TISSUE; ARTICLE; CHLOASMA; CONTROLLED STUDY; DRUG FORMULATION; DRUG MECHANISM; HYPERPIGMENTATION; IN VITRO STUDY; NONHUMAN; SKIN PENETRATION; SWINE; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 34548286932     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-93322007000200005     Document Type: Article

References (30)

1. ANSEL, H.C.; POPOVICH, N.G.; ALLEN, L.V. Farmacotécnica, formas farmacêuticas e sistemas de liberação defármacos. 6 ed. São Paulo: Editorial Premier, 2000. p. 300-301.
2. ARONSON, H. Correction factor for dissolution profile calculations. J. Pharm. Sci., Washington, v. 82, n. 11, 1993.
3. BATISTUZZO, J.A.O.; ITAYA, M.; ETO, Y. Formulário médico farmacêutico. 3.ed. São Paulo: Pharmabooks, 2006. 729p.
4. BENTLEY, M.V.L.B.; LOPEZ, R.F. V. Curso de permeação cutânea in vitro II. Modulo II. Apostila. Ribeirão Preto: FUNDEFARP, 2002. n.p.
5. BRONAUGH, R.L.; STEWART, R.F.; Methods for in vitro percutaneous absorption studies IV: preparation of the barrier layer. J. Pharm. Sci., Washington, v. 75, n. 5, p. 487-491, 1986.
6. BRONAUGH, R.L.; MAIBACH, H.I. Percutaneous absorption: Drugs - cosmetics - mechanisms - methodology. 3.ed. New York: Marcel Dekker, 1999. v. 97. 955 p.
7. CHOW, D.S.L.; KAKA, I.; WANG, T.I. Concentration-dependent enhancemente of 1-dodecylazacycloheptan-2-one, on the percutaneous penetration kinetics of triamcinolone acetonde. J. Pharm. Sci., Washington, v. 73, n. 12, p. 1794-1799, 1984.
8. ELLIS, D.A.F.; TAN, A.K.W.; ELLIS, C.S. Superficial micropeels: glicolic acid and alpha-hidroxy acid with kojic acid. F. P. Surg., New York, v. 11, n. 1, p. 15-21, 1995.
9. FLORENCE, A.T.; ATTWOOD, D. Princípios físico químicos em farmácia. São Paulo: Edusp, 2003. 732p.
10. FLYNN, G.L. Mechanism of percutaneous absorption from physicochemical evidence. In: BRONAUGH, R. L.; MAIBACH, H. I., (Ed.). Percutaneous absorption: mechanisms, methodology, drug delivery. 2 ed. New York: Marcel Dekker, 1989. p. 37.
11. GOMARA, F.L. Estudo depermeação cutânea in vitro do ácido kójico. Curitiba, 2003.125f. [Dissertação de Mestrado em Ciências Farmacêuticas. Universidade Federal do Paraná].
12. GOMARA, F.L.; CORRER, C.J.; SATO, M.E.O.; PONTAROLO, R. Desarrollo y validación de un método espectrofotométrico para cuantificacion de ácido kójico. Ars Pharm., Barcelona, v. 45, n. 2, p. 145-153, 2004.
13. LACHMAN, L.; LIEBERMAN, H.A.; KANIG, J.L. Teoria e prática na indústria farmacêutica. Lisboa: Fundação Calouste Gulbenkian, 2001. 539p.
14. MASINI, V.; BONTE, F.; MEYBECK, A.: WEPIERRE, J. Cutaneous bioavailability on hairless rats of tretinoin in liposomes or gel. J. Pharm. Sci., Washington, v. 82, n. 1, p. 17-21, 1993.
15. MICHNIAK, B.B.; CHAPMAN, J.M.; SEYDA, K.L. Facilitated transport of two models steroids by esters and amides of clofibric acid. J. Pharm. Sci., Washington, v. 82, n. 2, 214-219, 1993.
16. OECD Guidance document for the conduct of skin absorption studies. Paris: Organisation for economic cooperation and development, 2004. n.p.
17. PALUDETTI, A.L. Formulando em dermocosmética. Cosmet. Toilet., São Paulo, v. 7, p. 26-29, 1995.
18. PRISTA, L.N.; BAHIA, F.G.M.; VILAR, E. Dermofarmácia e cosmética. Porto: Associação Nacional das Farmácias, 1992. p. 145-150.
19. REIFENRATH, W.G. et al. Percutaneous penetration in the hairless dog, weanlihg pig an grafted athymic nude mouse: evaluation of models for predicting skin penetration in man. Br. J. Dermatol., Oxford, v. 27, p. 123-135, 1984.
20. SANCTIS, D.S. Emulsões aspectos técnicos e práticos para o desenvolvimento de formulações. Rev. Racine, São Paulo, p. 51, 2000.
21. SASAKI, H. et al. Enhancing effect of pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolona, acetonide, indomethacin and flubiprofen. J. Pharm Sci., Washington, v. 80, n. 6, p. 533-538, 1991.
22. SATO, K.; SUGIBAYASHI, K.; MORIMOTO, Y. Species differences in percutaneous absorption of nicorandil. J. Pharm. Sci., Washington v. 80, p. 104-107, 1991.
23. SCHUELLER, R.; ROMANOWSKI, P. Emulsões. Cosmet. Toilet., São Paulo, v. 12, p. 71-74, 2000.
24. SETHI, P.K.; AGHA, B.J. In vitro human cadaver skin retention and penetration of a lipophilic compound. Pharm. Res., New York, v. 10, n. 10, Suppl., PDD 7309, 1993.
25. SHAH, V.P.; BEHL, C.R.; FLYNN, G.L.; HIGUCHI, W.I.; SCHAEFER, H. Principles and criteria in the development and optimization of topical therapeutic products. Int. J. Pharm., Amsterdam, v. 82, p. 21-28, 1992 (a).
26. SHAH, V.P.; ELKINS, J.; SKELLY, J P. Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerato creams. J. Pharm Sci., Washington, v. 81, n. 1, p. 104-106, 1992 (b).
27. SHAH, V.P.; MAIBACH, H.I. Topical drug biovailability, bioequivalence, and penetration. New York: Plenum Press, 1993. 453p.
28. SMITH, E. W.; HAIGH, J.M. In vitro systems for assessment of drugs release from topical formulations and transmembrane permeation. In: BRONAUGH, R. L.; MAIBACH, H. I. Percutaneous absorption: mechanisms, methodology, drug delivery. 2 ed. New York: Marcel Dekker, 1989. p. 465-508.
29. TAUBER, U.; TODA, T. Biotransformation of Diflucortolon - vareriato in hairless mouse membrane. Arzneim-Forsch., Aulendorf, v. 26, n. 7b, p. 1484-1487, 1976.
30. WESTER, R.C.; MAIBACH, H. I. In vitro testing of topical pharmaceutical formulations. In: BRONAUGH, R.L.; MAIBACH, H.I. Percutaneous absorption: mechanisms, methodology, drug delivery. New York: Marcel Dekker, 1989. p. 653-659.